Teva said the purchase would drop them to expnad their offering of harder-to produce medical products such as soft-gel capees, topical and inhalant technologies and injectables, and make them profitable from specialty pharmaceuticals.
Teva said the purchase would help them to expand their offering of harder-to-produce medical products, such as soft-gel caps, topical and inhalant technologies and injectables, and increase their portfolio of specialty pharmaceuticals.